Scyllo-Inositol

CAS No. 488-59-5

Scyllo-Inositol( Scyllitol )

Catalog No. M21272 CAS No. 488-59-5

Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 51 In Stock
50MG 157 In Stock
100MG 262 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Scyllo-Inositol
  • Note
    Research use only, not for human use.
  • Brief Description
    Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
  • Description
    Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Scyllitol
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    amyloid-β
  • Research Area
    Neurological Disease
  • Indication
    Alzheimer's Disease

Chemical Information

  • CAS Number
    488-59-5
  • Formula Weight
    180.16
  • Molecular Formula
    C6H12O6
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:5 mg/mL (27.75 mM; Need ultrasonic)
  • SMILES
    O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ibrahim T Mclaurin J A . α-Synuclein aggregation seeding and inhibition by scyllo-inositol[J]. Biochemical & Biophysical Research Communications 2015:S0006291X15310482.
molnova catalog
related products
  • V-9-M Cholecystokini...

    V-9-M Cholecystokinin nonapeptide (Prepro CCK Fragment V-9-M) is a precursor compound of cholecystokinin (CCK).

  • Pinostrobin

    Pinostrobin, a potent flavonoid inducer, exerts a neuroprotective effect against Aα2(25-35)-induced neurotoxicity in PC12 cells.

  • β-amyloid 1-11

    Anionic interaction of Beta-amyloid (1-11) with Factor XII is suspected to cause massive activation of the C4 (complement 4) system in the cerebrospinal fluid of Alzheimer’s disease patients.